| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.57B | 2.39B | 1.91B | 1.81B | 2.27B | 1.53B |
| Gross Profit | 954.86M | 919.92M | 737.05M | 696.64M | 861.32M | 554.26M |
| EBITDA | 657.29M | 597.59M | 427.63M | 435.03M | 661.40M | 423.38M |
| Net Income | 426.54M | 399.71M | 280.30M | 254.22M | 437.75M | 312.77M |
Balance Sheet | ||||||
| Total Assets | 3.79B | 3.82B | 3.17B | 2.97B | 2.89B | 2.43B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 1.14B | 728.80M | 720.69M | 833.70M | 846.85M |
| Total Debt | 432.90M | 438.19M | 415.41M | 374.87M | 197.63M | 175.33M |
| Total Liabilities | 1.55B | 1.64B | 1.33B | 1.36B | 1.44B | 1.04B |
| Stockholders Equity | 2.25B | 2.17B | 1.84B | 1.61B | 1.44B | 1.38B |
Cash Flow | ||||||
| Free Cash Flow | 783.56M | 808.91M | 261.73M | 85.54M | 727.92M | 565.69M |
| Operating Cash Flow | 817.31M | 848.61M | 328.46M | 136.27M | 736.60M | 579.84M |
| Investing Cash Flow | -198.38M | -265.06M | -70.41M | -3.00M | -273.91M | -99.75M |
| Financing Cash Flow | -397.21M | -329.07M | -250.59M | -240.46M | -459.06M | -26.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $11.81B | 23.90 | 31.39% | 1.12% | 27.00% | 63.47% | |
76 Outperform | $11.84B | 20.53 | 11.73% | 1.51% | 7.54% | 2.73% | |
71 Outperform | $5.00B | 20.80 | 51.98% | 4.26% | 51.19% | 456.59% | |
70 Outperform | $12.14B | 27.98 | 20.29% | 1.18% | 20.99% | 25.02% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $5.77B | 24.59 | 19.30% | 1.77% | 12.77% | 36.43% | |
52 Neutral | $10.83B | 18.08 | 6.29% | 2.92% | -5.41% | 25.28% |
Houlihan Lokey’s latest earnings call paints a picture of robust growth, with the company reporting significant increases in both revenues and earnings. The sentiment during the call was largely positive, driven by strong performances in Corporate Finance and international markets. However, there were some concerns about a slowdown in restructuring activities and a decrease in average transaction fees. Overall, the positive aspects of the earnings call outweighed the challenges, reflecting a strong financial position for the company.
Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory, serving clients worldwide with a commitment to independent advice and intellectual rigor.
On September 30, 2025, Houlihan Lokey‘s Board of Directors approved an increase in the board size from ten to eleven members, appointing R. Scott Mund as an independent Class II director effective October 1, 2025. Mr. Mund, a partner at Deloitte LLP with extensive experience in advising multinational companies on M&A and corporate governance, will serve until the 2026 Annual Meeting of Stockholders. His appointment to the Nominating and Corporate Governance Committee is expected to enhance the company’s strategic planning and governance capabilities. Mr. Mund will receive standard compensation, including an award of restricted shares valued at $100,000, vesting over three years.
The most recent analyst rating on (HLI) stock is a Buy with a $230.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.
On September 17, 2025, Houlihan Lokey, Inc. held its annual meeting of stockholders where key proposals were voted on. Stockholders elected three Class I directors to the board, approved the executive compensation on an advisory basis, and ratified KPMG LLP as the independent public accounting firm for the fiscal year ending March 31, 2026. These decisions are pivotal for the company’s governance and financial oversight, potentially impacting its strategic direction and stakeholder confidence.
The most recent analyst rating on (HLI) stock is a Buy with a $213.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.
On August 19, 2025, Houlihan Lokey, Inc. and its subsidiaries entered into a Second Amendment to their Credit Agreement, originally dated August 23, 2019. The amendment increases the revolving credit commitments from $100 million to $150 million, reduces interest rate margins and fees, modifies covenant restrictions, and extends the credit facility’s maturity to August 19, 2030. These changes are expected to enhance the company’s financial flexibility and operational capacity, potentially impacting its market positioning and stakeholder interests positively.
The most recent analyst rating on (HLI) stock is a Buy with a $218.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.